Google
PEPG — PEPGEN LTD (Healthcare >> Biotechnology)
PEPG FAQ
What is PEPG's ROE?
PEPGEN LTD reports a Return on Equity (ROE) of -57.63%.
What is PEPG's dividend yield?
PEPGEN LTD offers a dividend yield of 0.00%.
What is PEPG's Deepscope Quality Score?
Deepscope rates PEPG's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PEPG?
Deepscope's AI Timing Score for PEPG is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PEPG belong to?
PEPGEN LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.51
Price
-0.04
(-2.65%)
Day Change
|
|
|---|
PEPG Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.51 |
| PBV / Sector |
0.77 / 4.79
GREAT
|
| Earning Per Share | -1.13 |
| PE / Sector |
N/A / 18.05
|
| PEG or PE/Growth / Sector |
N/A / 0.62
|
| Average 1M Daily Value |
0.91 M
GREAT
|
| Average 1W Daily Value |
0.80 M
GREAT
|
| Yếu tố Kỹ thuật |
|
57% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
37% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-12 09:43:53 |
| Symbol | PEPG |
| Name | PEPGEN LTD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 69.17 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 103.06 / 9,010.81 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 321 Harrison Avenue, Boston, MA, United States, 02118
Phone: 781 797 0979
Website: https://www.pepgen.com
Employees: 56
Sector: Healthcare >> Biotechnology
Description: PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
